Nasopharyngeal carcinoma (NPC) is rare, albeit relatively common in southern China, southeast Asia, the Arctic, and North Africa ([@bib2]). NPC risk factors include male gender, increased age, southern Chinese ethnicity, less education, consumption of salted fish and other preserved foods containing elevated levels of nitrate/nitrosamines, reduced fruit and vegetable consumption, cigarette smoking, betel nut chewing, alcohol consumption, and occupational exposures ([@bib2]). Epstein--Barr virus (EBV), a ubiquitous herpesvirus that infects over 90% of adults worldwide, is believed to be necessary, but not sufficient for developing NPC ([@bib2]). Longitudinal studies in China and Taiwan have shown that positivity for anti-EBNA1 IgA, anti-VCA IgA, and anti-DNase antibodies were associated with a significantly elevated NPC risk ([@bib18], [@bib17]; [@bib4]; [@bib9]; [@bib5]; [@bib10]; [@bib16]).

Whether non-viral risk factors act independently of anti-EBV serological responses or mediate EBV effects on NPC development is not known. To address this question, we evaluated the association between non-viral NPC risk factors and EBV serological responses in a group of healthy individuals from high-risk NPC multiplex families in Taiwan.

Methods
=======

Participants in the present study were part of the NPC multiplex family study in Taiwan, previously described ([@bib12]; [@bib14]; [@bib15]). Over 300 NPC multiplex families were identified and recruited, including 659 NPC cases and 2557 unaffected parents, siblings, spouses, and children.

Risk factors were assessed by questionnaire for all individuals by a trained nurse. Sociodemographic characteristics were age, gender, ethnicity, and education. Lifestyle factors included smoking, betel use, and alcohol use. Occupational exposures evaluated included duration of formaldehyde exposure and wood exposure.

Dietary intake during ages 10--30 (representing consumption during adolescence and adulthood) was assessed by food frequency questionnaire, such as: consumption of salted fish, other preserved foods (salted meat, smoked foods, preserved eggs, fried/fermented bean curd, fermented rice, and fermented flour sauce), and fruits and vegetables. Other preserved foods were combined into a single variable by summing across the variables, and dividing into categories corresponding to the questionnaire diet frequency categories.

Serum from participants was tested for the following EBV antibody markers: anti-VCA IgA by the immunofluorescent assay, anti-EBNA1 IgA by enzyme-linked immunosorbent assay, and anti-DNase by an enzyme neutralisation assay as previously described ([@bib12]). For the present analysis, a total of 2393 unaffected family members from 319 NPC multiplex families with data on EBV serology were included.

All estimates in this analysis were obtained using conditional logistic regression with the SAS PHREG procedure (SAS version 9.2), conditioning on families to account for familial correlations ([@bib11]). We chose anti-EBNA1 IgA (at a cut-off of OD~405~ ⩾0.10) as the primary outcome of interest for this analysis, because this measure was optimised for high sensitivity and most strongly predicted NPC risk in our family study ([@bib16]). In secondary analyses, we evaluated (1) anti-EBNA1 IgA (OD~405~⩾0.20) with an alternative cut-off used for studies of sporadic NPC, (2) anti-VCA IgA based on the cut-off of 1 : 10 or greater dilution of serum, and (3) DNase neutralising activity, based on a cut-off optimised for high sensitivity in our family study (positivity cut-off=160 or more neutralising units; [@bib16]). We also evaluated anti-EBNA1 IgA without the more ambiguous group (0.10⩽OD~405~\<0.20), so that a clean, positive group (OD~405~⩾0.20) was compared with a clean, negative group (OD~405~\<0.10). However, the results resembled those of the original outcome (OD~405~⩾0.20 *vs* OD~405~\<0.20), and therefore, were not presented.

Variables selected for consideration in the adjusted models were based on significant or borderline significant associations (based on the 95% confidence intervals (CI)) with EBNA1 positivity (OD~405~⩾0.10). Dose response was based on calculating overall Wald *P*-values for categorical variables.

Results
=======

There were a total of 2393 unaffected family members in this study. The mean age was 46 years (47 in women and 44 in men), and 53% were women.

Overall, there were 1180 (49.3%) individuals seropositive for anti-EBNA1 IgA (OD~405~⩾0.10). In the full model, being 31--40 years old and 41--50 years old (*vs* 18--30 years) were inversely associated with anti-EBNA1 IgA positivity (adjusted OR (aOR)=0.51, 95% CI=0.32--0.83 and aOR=0.57, 95% CI=0.35--0.91, respectively), but associations with the older age groups were not significant. There was a suggestive, nonsignificant association between GuangDong firm salted fish (*vs* never; aOR=1.8) and anti-EBNA1 positivity ([Table 1](#tbl1){ref-type="table"}).

A total of 384 (16.1%) individuals were seropositive for anti-EBNA1 IgA (OD~405~⩾0.20). Current alcohol use (*vs* never use) was associated with anti-EBNA1 IgA positivity (aOR=1.7, 95% CI=1.0--2.8; [Table 1](#tbl1){ref-type="table"}). Former betel use (*vs* never use; aOR=1.9) and GuangDong firm salted fish, and both mouldy and firm salted fish (*vs* never; aORs 1.6--1.9) were nonsignificantly associated with anti-EBNA1 IgA positivity. There were nonsignificantly inverse associations with anti-EBNA1 IgA positivity for the three middle age groups (31--40, 41--50, and 51--60 years; aORs 0.63--0.86), but no association with the oldest age group ([Table 1](#tbl1){ref-type="table"}).

A total of 491 (26.3%) individuals were seropositive for anti-VCA IgA. Compared with the youngest age group (less than 30), the oldest age group (greater than 60; aOR=1.9, 95% CI=1.1--3.5) was associated with anti-VCA IgA positivity (*P*-trend=0.012). Not reaching statistical significance, GuangDong firm salted fish (*vs* never; aOR=2.0, 95% CI=0.88--4.5) was associated with anti-VCA IgA positivity ([Table 1](#tbl1){ref-type="table"}).

A total of 767 (32.1%) individuals were seropositive for anti-DNase. Former and current betel use (*vs* never use) and GuangDong firm salted fish (*vs* never) were significantly associated with anti-DNase seropositivity (aORs 2.2--2.9). Males were at lowered risk of anti-DNase seropositivity compared with females (aOR=0.64, 95% CI=0.43--0.94). Age greater than 30 (*vs* less than 30) was associated with anti-DNase seropositivity (aORs 1.8--2.5, *P*-trend=0.81).

Discussion
==========

With a couple of notable exceptions discussed below, we saw little evidence to indicate that non-viral NPC risk factors influence anti-EBV seroreactivity. This suggests that non-viral NPC risk factors are unlikely to influence NPC risk by altering anti-EBV serological profiles.

We observed a U-shaped curve for age, with anti-EBNA1 IgA positivity being higher among the youngest and oldest, and lower among the middle age categories. The higher antibody positivity rate observed among older individuals, also seen for anti-VCA IgA, could reflect immunosenescence in older age, leading to more frequent viral lytic reactivation ([@bib1]). The fact that anti-EBNA1 IgA positivity, but not other markers, was also higher among the youngsters, is not clearly understood.

There was a suggestive elevated risk for all EBV markers (aORs 1.6--2.7) associated with GuangDong firm salted fish, but not mouldy fragrant fish. In an *in vitro* study, aqueous extracts of Cantonese salted fish activated EBV lytic replication in Raji cells in a dose-dependent manner by causing cells to express EBV early antigen ([@bib13]). However, it is unclear why one type of GuangDong salted fish would activate EBV, but not another type.

A significant association was observed between betel use and anti-DNase positivity, and was suggestive for anti-EBNA1. Although betel nut use is classified as a group 1 carcinogen in humans, there is no data on whether or not betel use can lead to EBV reactivation ([@bib6]). Betel nut ingredients have induced inflammation *in vitro*, supporting the biological plausibility of this association ([@bib7], [@bib8]; [@bib3]).

There may be recall bias of diet between the ages of 10--30, such that young subjects may be prone to recall their diet in adolescence and older subjects prone to recall diet in their adulthood. EBV serology was measured at only one point in time and may not capture all episodes of EBV lytic replication. We would not have detected associations with other aspects of EBV exposure and/or host response to EBV. Our results may have been affected by the reproducibility for anti-VCA IgA testing, which was modest (agreement∼68%, *κ*∼0.29--0.38; [@bib12]). Our findings for a high-risk population may not represent that of the general population, and associations may be attenuated due to similarity of exposures within high-risk families ([@bib14]). However, by studying unaffected relatives from NPC multiplex families, the population is enriched in terms of EBV IgA antibody positivity, which occurs at much lower frequencies in the general population ([@bib12]). Additional strengths of the study include the large sample size, recruitment through cases identified from the national cancer registry, availability of detailed risk factor information, as well as multiple EBV serological markers.

In summary, the majority of NPC risk factors were not found to be significantly associated with anti-EBNA1 IgA positivity, the strongest predictor of NPC risk in our study population. In conclusion, our data suggest that non-viral NPC risk factors affect NPC risk via mechanisms other than through effects on EBV reactivation or host antibody responses to such infections.
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###### Adjusted odds ratios (aORs)^a^ for the associations between NPC risk factors and risk of EBV antibody seropositivity for anti-EBNA IgA (OD~405~⩾0.1), anti-EBNA IgA (OD~405~⩾0.2), anti-VCA IgA (⩾1:10), and anti-DNase (⩾160)

                               **Anti-EBNA1 IgA-positive (⩾0.1)**   **Anti-EBNA1 IgA-positive (⩾0.2)**   **Anti-VCA IgA-positive (⩾1:10)**   **Anti-DNase-positive (⩾160)**                                                                                                     
  ---------------------------- ------------------------------------ ------------------------------------ ----------------------------------- -------------------------------- ------ ----- ------ ------------------ ------ ----- ------ ------------------ ------ ----- ------ -------------------
  *Age*                                                                                                                                                                                                                                                                         
   18--30                      429                                  216                                  50.4                                1.0 (Reference)                  429    64    14.9   1.0 (Reference)    307    66    21.5   1.0 (Reference)    429    99    23.1   1.0 (Reference)
   31--40                      558                                  250                                  44.8                                0.51 (0.32, 0.83)                558    74    13.3   0.63 (0.34, 1.2)   424    97    22.9   1.1 (0.66, 1.9)    558    194   34.8   2.5 (1.5, 4.3)
   41--50                      546                                  268                                  49.1                                0.57 (0.35, 0.91)                546    90    16.5   0.70 (0.38, 1.3)   429    112   26.1   1.7 (0.96, 2.8)    546    163   29.9   1.8 (1.1, 3.1)
   51--60                      372                                  191                                  51.3                                0.78 (0.48, 1.3)                 372    65    17.5   0.86 (0.46, 1.6)   314    86    27.4   1.6 (0.96, 2.8)    372    133   35.8   2.1 (1.2, 3.6)
   \>60                        488                                  255                                  52.3                                0.77 (0.45, 1.3)                 488    91    18.7   1.1 (0.58, 2.2)    390    130   33.3   1.9 (1.1, 3.5)     488    178   36.5   1.8 (1.0, 3.3)
   *P*-trend                                                                                                                                 0.74                                                 0.18                                   0.012                                  0.81
                                                                                                                                                                                                                                                                                 
  *Gender*                                                                                                                                                                                                                                                                      
   Female                      1269                                 588                                  46.3                                1.0 (Reference)                  1269   187   14.7   1.0 (Reference)    994    275   27.7   1.0 (Reference)    1269   429   33.8   1.0 (Reference)
   Male                        1124                                 592                                  52.7                                1.1 (0.73, 1.5)                  1124   197   17.5   1.1 (0.68, 1.7)    870    216   24.8   0.81 (0.54, 1.2)   1124   338   30.1   0.64 (0.43, 0.94)
                                                                                                                                                                                                                                                                                 
  *Smoking*                                                                                                                                                                                                                                                                     
   Never                       1616                                 762                                  47.2                                1.0 (Reference)                  1616   235   14.5   1.0 (Reference)    1260   327   26.0   1.0 (Reference)    1616   514   31.8   1.0 (Reference)
   Former                      186                                  105                                  56.5                                1.7 (0.91, 3.0)                  186    43    23.1   1.4 (0.71, 2.8)    148    39    26.4   0.98 (0.52, 1.9)   186    59    31.7   0.66 (0.35, 1.3)
   Current                     585                                  310                                  53.0                                0.95 (0.63, 1.4)                 585    104   17.8   0.97 (0.58, 1.6)   450    123   27.3   1.3 (0.86, 2.1)    585    192   32.8   1.5 (0.97, 2.3)
                                                                                                                                                                                                                                                                                 
  *Betel*                                                                                                                                                                                                                                                                       
   Never                       2143                                 1033                                 48.2                                1.0 (Reference)                  2143   330   15.4   1.0 (Reference)    1669   436   26.1   1.0 (Reference)    2143   675   31.5   1.0 (Reference)
   Former                      84                                   52                                   61.9                                1.3 (0.66, 2.8)                  84     25    29.8   1.9 (0.84, 4.2)    69     22    31.9   1.0 (0.45, 2.2)    84     31    36.9   2.9 (1.4, 6.1)
   Current                     159                                  91                                   57.2                                1.3 (0.72, 2.4)                  159    27    17.0   1.1 (0.51, 2.4)    119    31    26.1   0.77 (0.39, 1.5)   159    58    36.5   2.2 (1.2, 4.2)
                                                                                                                                                                                                                                                                                 
  *Alcohol*                                                                                                                                                                                                                                                                     
   Never                       1818                                 873                                  48.0                                1.0 (Reference)                  1818   272   15.0   1.0 (Reference)    1409   374   26.5   1.0 (Reference)    1818   584   32.1   1.0 (Reference)
   Former                      100                                  56                                   56.0                                0.8 (0.36, 1.6)                  100    23    23.0   0.7 (0.28, 1.8)    81     18    22.2   0.62 (0.28, 1.4)   100    33    33.0   0.68 (0.32, 1.5)
   Current                     469                                  248                                  52.9                                1.1 (0.77, 1.7)                  469    87    18.6   1.7 (1.0, 2.8)     368    97    26.4   1.1 (0.74, 1.7)    469    148   31.6   1.2 (0.82, 1.9)
                                                                                                                                                                                                                                                                                 
  *Duration of formaldehyde*                                                                                                                                                                                                                                                    
   None                        1042                                 484                                  46.5                                1.0 (Reference)                  1042   182   17.5   1.0 (Reference)    1042   301   28.9   1.0 (Reference)    1042   382   36.7   1.0 (Reference)
   \<10 years                  155                                  71                                   45.8                                1.3 (0.84, 2.0)                  155    18    11.6   0.78 (0.42, 1.5)   155    36    23.2   0.77 (0.48, 1.3)   155    58    37.4   1.1 (0.71, 1.7)
   ⩾10 years                   216                                  122                                  56.5                                1.3 (0.84, 2.0)                  216    53    24.5   1.4 (0.83, 2.4)    216    81    37.5   1.1 (0.67, 1.7)    216    81    37.5   1.1 (0.67, 1.6)
   *P*-trend                                                                                                                                 0.14                                                 0.25                                   0.87                                   0.78
                                                                                                                                                                                                                                                                                 
  *Fruits and vegetables*                                                                                                                                                                                                                                                       
   Less than once a day        257                                  142                                  55.3                                1.0 (Reference)                  257    47    18.3   1.0 (Reference)    194    51    26.3   1.0 (Reference)    257    93    36.2   1.0 (Reference)
   1--2 times a day            1324                                 645                                  48.7                                0.88 (0.54, 1.4)                 1324   202   15.3   0.98 (0.53, 1.8)   1025   269   26.2   0.86 (0.51, 1.5)   1324   411   31.0   0.69 (0.42, 1.1)
   2 or more times a day       784                                  377                                  48.1                                0.86 (0.51, 1.5)                 784    128   16.3   0.86 (0.45, 1.6)   622    162   26.1   0.95 (0.54, 1.7)   784    248   31.6   0.80 (0.47, 1.4)
   *P*-trend                                                                                                                                 0.62                                                 0.46                                   0.99                                   0.68
                                                                                                                                                                                                                                                                                 
  *GuangDong salted fish*                                                                                                                                                                                                                                                       
   Never                       1941                                 960                                  49.5                                1.0 (Reference)                  1941   300   15.5   1.0 (Reference)    1474   410   27.8   1.0 (Reference)    1941   610   31.4   1.0 (Reference)
   Mouldy fragrant fish only   45                                   23                                   51.1                                1.4 (0.58, 3.3)                  45     6     13.3   0.78 (0.22, 2.7)   42     10    23.8   1.0 (0.38, 2.7)    45     15    33.3   0.76 (0.31, 1.9)
   Firm fish only              60                                   36                                   60.0                                1.8 (0.86, 3.9)                  60     14    23.3   1.6 (0.58, 4.2)    57     18    31.6   2.0 (0.88, 4.5)    60     25    41.7   2.7 (1.1, 6.5)
   Both mouldy and firm fish   98                                   40                                   40.8                                0.98 (0.51, 1.9)                 98     24    24.5   1.9 (0.85, 4.3)    90     14    15.6   0.84 (0.40, 1.8)   98     35    35.7   1.3 (0.7, 2.5)

Adjusted odds ratios are from full models containing the following variables: age, gender, smoking, betel use, alcohol use, duration of formaldehyde exposure, fruit and vegetable intake, and type of salted fish intake.
